{"transactions":[{"id":754209,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":30000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754208,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from March 27, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754207,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754206,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from September 7, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754205,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":25000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754204,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On May 29, 2026, the Issuer's stockholders approved an option repricing at an exercise price of $1.59 per share (the \"Repricing\") of the stock options held by current employees and other service providers previously priced at or over $5. The Repricing is subject to the Reporting Person remaining in service to the Issuer through May 29, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":100000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-05-29","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754203,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":5.44,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754202,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from March 27, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":6,"expiration_date":"2033-03-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754201,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":9.87,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754200,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from September 7, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":0,"derivative":{"exercise_price":10.78,"expiration_date":"2032-09-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754199,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":14.67,"expiration_date":"2032-01-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":754198,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-03T00:31:37.000Z","date":"2026-05-29","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":100000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On May 29, 2026, the Issuer's stockholders approved the repricing of the option. As further described in footnote 6, all other terms of the option remain unchanged."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":14.76,"expiration_date":"2031-04-28","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-26-069622","document":"tm2616725-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000110465926069622/tm2616725-2_4seq1.xml","form_type":"4"}},{"id":931037,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-26T21:39:43.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 22, 2026 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":225000,"derivative":{"exercise_price":1.59,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001610717-26-000026","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000026/form4.xml","form_type":"4"}},{"id":931036,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-26T21:39:43.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":112500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 50% of the RSUs vest on May 20, 2027 and 50% of the RSUs vest on March 20, 2029, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":133736,"source":{"system":"sec-edgar","filing":"0001610717-26-000026","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000026/form4.xml","form_type":"4"}},{"id":933204,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-23T01:50:42.000Z","date":"2026-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1715,"price":1.55,"value":2658.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":21236,"source":{"system":"sec-edgar","filing":"0001610717-26-000017","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071726000017/form4.xml","form_type":"4"}},{"id":1153393,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-09T21:59:16.000Z","date":"2025-05-07","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of May 7, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":0.9462,"expiration_date":"2035-05-07","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001610717-25-000117","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000117/form4.xml","form_type":"4"}},{"id":1297294,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-23T00:51:11.000Z","date":"2025-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1711,"price":1.39,"value":2378.29,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":22951,"source":{"system":"sec-edgar","filing":"0001610717-25-000015","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000015/form4.xml","form_type":"4"}},{"id":1304953,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-10T21:03:29.000Z","date":"2025-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1711,"price":1.57,"value":2686.27,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,401 shares acquired on May 15, 2023 pursuant to the Coherus BioSciences, Inc. Employee Stock Purchase Plan."}],"balance_after":24662,"source":{"system":"sec-edgar","filing":"0001610717-25-000010","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000010/form4.xml","form_type":"4"}},{"id":1307626,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-08T01:51:10.000Z","date":"2025-01-03","kind":"grant","planned":false,"acquired":true,"shares":160000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of January 3, 2025 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":160000,"derivative":{"exercise_price":1.66,"expiration_date":"2035-01-03","underlying":"Common Stock","underlying_shares":160000},"source":{"system":"sec-edgar","filing":"0001610717-25-000008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071725000008/form4.xml","form_type":"4"}},{"id":1436728,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-09T20:11:03.000Z","date":"2024-08-07","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/4th of the total number of shares on the one year anniversary of August 1, 2024 and 1/48th of the total number of shares in successive, equal monthly installments thereafter, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1.24,"expiration_date":"2034-08-07","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001610717-24-000424","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000424/form4.xml","form_type":"4"}},{"id":1672749,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-24T01:04:19.000Z","date":"2024-01-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1707,"price":2.44,"value":4165.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld by the Issuer to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3. No shares were sold by the Reporting Person in connection with the foregoing transaction."}],"balance_after":22972,"source":{"system":"sec-edgar","filing":"0001610717-24-000037","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000037/form4.xml","form_type":"4"}},{"id":1682348,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-01-10T00:37:09.000Z","date":"2024-01-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1707,"price":2.87,"value":4899.09,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."}],"balance_after":24679,"source":{"system":"sec-edgar","filing":"0001610717-24-000023","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000023/form4.xml","form_type":"4"}},{"id":1687131,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-04T22:14:31.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the total number of shares subject to the option shall vest in successive, equal monthly installments measured from January 2, 2024, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":125000,"derivative":{"exercise_price":3.14,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001610717-24-000012","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071724000012/form4.xml","form_type":"4"}},{"id":1853958,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-15T20:41:15.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 50% of the shares on each anniversary measured from June 13, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":5.44,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001610717-23-000167","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000161071723000167/form4.xml","form_type":"4"}},{"id":1935562,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-03-29T20:30:47.000Z","date":"2023-03-27","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from March 27, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":6,"expiration_date":"2033-03-27","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001140361-23-014545","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000114036123014545/form4.xml","form_type":"4"}},{"id":2047281,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-01-24T21:49:10.000Z","date":"2023-01-20","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3 of the RSUs vest annually on January 20 of each year, with the first 1/3 vesting on January 20, 2024 and with the RSUs being fully vested on January 20, 2026, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":26386,"source":{"system":"sec-edgar","filing":"0001567619-23-001210","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761923001210/doc1.xml","form_type":"4"}},{"id":2057301,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2023-01-10T21:40:35.000Z","date":"2023-01-07","kind":"tax_withholding","acquired":false,"shares":1699,"price":9.58,"value":16276.42,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares automatically withheld to pay related tax liability in connection with the vesting of restricted stock units in accordance with Rule 16b-3."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1 share acquired on November 15, 2022, pursuant to Coherus BioSciences, Inc. Employee Stock Purchase Plan."}],"balance_after":13886,"source":{"system":"sec-edgar","filing":"0001567619-23-000765","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761923000765/doc1.xml","form_type":"4"}},{"id":2059957,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-01-06T23:16:29.000Z","date":"2023-01-04","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from January 4, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":9.87,"expiration_date":"2033-01-04","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001567619-23-000697","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761923000697/doc1.xml","form_type":"4"}},{"id":2162056,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":42315,"kind":"person","name":"McMichael Bryan J","position":1,"cik":"0001944868","reported_name":"McMichael Bryan J","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-09T21:37:06.000Z","date":"2022-09-07","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/48th of the total number of shares subject to the option in successive, equal monthly installments measured from September 7, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":15000,"derivative":{"exercise_price":10.78,"expiration_date":"2032-09-07","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001567619-22-017242","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1512762/000156761922017242/doc1.xml","form_type":"4"}}]}